Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154112 · ClinicalTrials.gov registry record
Validation of a Novel Oxygen Consumption Measurement Technique in Neonates
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 14
- Enrollment target
NCT03154112: Completed study, sponsored by Boston Children's Hospital.
NCT03154112 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03154112 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The measurement of how much oxygen a baby consumes provides important information about the health of the baby, and of how much energy they are consuming. Currently, there is no device which measures either oxygen consumption, or another variable that depends on oxygen consumption - resting energy expenditure - in neonates or infants. Our group has developed a new device which can attach to any ventilator and measures these two variables with accuracy in the preclinical setting, including in rodents as small as severely preterm infants. The purpose of this study is to compare measurements of oxygen consumption and energy expenditure in neonates using this device and comparing it with a gold standard which is rarely used, a Douglas bag method in which expired gas is collected and later analyzed.
Interventions
- DEVICE Measurement of oxygen consumption and caloric expenditure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2019-07-01 |
What the finished NCT03154112 record still lists
NCT03154112 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measurement of oxygen consumption and caloric expenditure is the first listed.
NCT03154112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03154112 about?
NCT03154112 is a clinical study titled "Validation of a Novel Oxygen Consumption Measurement Technique in Neonates". The measurement of how much oxygen a baby consumes provides important information about the health of the baby, and of how much energy they are consuming. Currently, there is no device which measures either oxygen consumption, or another variable that depends on oxygen consumption - resting energy e...
What is the current status of trial NCT03154112?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2017-07-05. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT03154112?
The interventions under investigation include: Measurement of oxygen consumption and caloric expenditure (DEVICE).
Who is sponsoring clinical trial NCT03154112?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy